mRNA-Impfstoff in der Schweiz: Die Zulassung und ihre Bedeutung für die Impfkampagne
The Future of mRNA Vaccines Beyond COVID-19 The recent approval of Moderna‘s RSV-mRNA vaccine, mResvia, in Switzerland marks a significant milestone, showcasing the expanding potential of mRNA technology in combating various infectious diseases. As we look ahead, several future trends are emerging, highlighting the broader applications and transformative impact of mRNA vaccines. Expanding Beyond COVID-19 … Read more